| Ms Cynthia Reiffen, LICSW | |
|
111 Church St, Laconia, NH 03246-3432 | |
| (603) 524-1100 | |
| Not Available |
| Full Name | Ms Cynthia Reiffen |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 111 Church St, Laconia, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568753929 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 1574 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Cynthia Reiffen, LICSW 111 Church St, Laconia, NH 03246-3432 Ph: (603) 524-1100 | Ms Cynthia Reiffen, LICSW 111 Church St, Laconia, NH 03246-3432 Ph: (603) 524-1100 |
News Archive
Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical results presented at the AACR-IASLC (American Academy of Cancer Research – International Association for the Study of Lung Cancer) Joint Conference based on work done at Synta and at the Dana-Farber Cancer Institute in Boston showed that STA-9090, a potent, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated potent activity against 100% of all non-small cell lung cancer cell lines tested, including those with EGFR, HER2 or KRAS mutations including the EGFR T790 mutation that is present in roughly 50% of cases of erlotinib or gefitinib resistance.
Researchers collected health and injury data during a one-year period on more than 2,500 adults living in Colorado. More than one out of four (26 percent) of the extremely obese male participants reported personal injuries, and more than one out of five (21.7 percent) extremely obese women also reported injuries.
A combination of radionuclide therapy and immunotherapy has proven successful in slowing the progression of prostate cancer and increasing survival time, according to new research published in the February issue of The Journal of Nuclear Medicine.
Emerging Healthcare Solutions, Inc. announced today that management has formally delivered an actionable Term Sheet to ThromboVision for review and that follow up communications have been very favorable.
UNION therapeutics A/S (UNION) announced today that the results of a phase 1 study of inhaled and intranasal niclosamide (UNI911) have been published by The Lancet Regional Health – Europe.
› Verified 5 days ago
Chelsea Kendrick, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 40 Beacon St E, Laconia, NH 03246 Phone: 603-524-1100 | |
Ms. Shirley Ann Sthilaire, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 831 Union Ave, Laconia, NH 03247 Phone: 603-528-7728 Fax: 603-528-7728 | |
Marisa Fritchy, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 40 Beacon St E, Laconia, NH 03246 Phone: 603-524-1100 | |
Elaine Demello, MSW.,LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 111 Church St, Laconia, NH 03246 Phone: 603-524-1100 | |
Hammond Fuller Brown, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 67 Water St, Suite 205, Laconia, NH 03246 Phone: 603-528-6086 | |
Ms. Linda A Lett, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 95 Water St, Laconia, NH 03246 Phone: 603-524-5835 Fax: 603-524-7862 | |
Gary L Chandler, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 111 Church St, Laconia, NH 03246 Phone: 603-524-1100 |